Literature DB >> 2145911

Weekly low dosage epirubicin in advanced breast cancer.

A R Dixon, J F Robertson, E Athanassiou, L Jackson, R W Blamey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2145911     DOI： 10.1016/0277-5379(90)90170-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  3 in total

1.  Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy for advanced breast cancer.

Authors:  M Bontenbal; A S Planting; C J Rodenburg; A Dees; J Verweij; C C Bartels; J Alexieva-Figusch; W L van Putten; J G Klijn
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 2.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

3.  Epirubicin as a single agent therapy for the treatment of breast cancer--a pharmacokinetic and clinical study.

Authors:  S Eksborg; L Hardell; N O Bengtsson; M Sjödin; B Elfsson
Journal:  Med Oncol Tumor Pharmacother       Date:  1992
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.